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Treatment of acute postoperative pain is an essential part of perioperative care 
and if left untreated could complicate the healing period. Ketamine blocks nocicep-
tive pain and pain arising from inflammation. Therefore, it is potentially beneficial 
in the postoperative period. After systematic review using “MEDLINE/PubMed 
(NLM)” database, we analyzed 18 studies published during 2011–2020 and found 
that 0.5 mg/kg/h ketamine bolus and 0.1–0.25 mg/kg/h ketamine infusion to be the 
most effective dose to alleviate postoperative acute pain. Ketamine, when compared 
with a placebo, did not have any impact on patients’ satisfaction with postopera-
tive pain management and overall well-being. Only three studies revealed more 
frequent adverse reactions to ketamine after surgery suggesting that ketamine did 
not have any impact on patients’ postoperational rehabilitation. So, it is the option 
to recommend low-dose ketamine to be part of multimodal analgesia in acute severe 
postoperative pain treatment. It can be used in both opioid-dependent and opioid-
tolerant patients. Ketamine bolus should be ≤0.35 mg/kg and infusion ≤1 mg/kg/h. 
One should avoid the use of ketamine in pregnant women, people with cardiovas-
cular diseases, acute psychosis, impaired liver function, increased intracranial, and 
intraocular pressure. Intranasal ketamine may be considered for children during 
procedures outside of the operation room.
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1. Introduction
Treatment of acute postoperative pain is an important part of perioperative care. 
Insufficient analgesia is related to adverse outcomes such as immunosuppression, 
hyperglycemia, aggravated early rehabilitation, deterioration in patients’ quality of 
life, more common postoperative complications, a longer period of recovery after 
surgery, and progress from acute to chronic pain [1, 2].
Ketamine, a N-methyl-d-aspartate (NMDA) receptor antagonist, is a cheap 
and potentially opioid-sparing effect having drug, which in recent years attains 
more recognition for multimodal pain management [1, 3, 4]. NMDA receptors are 
related to nociceptive pain and pain arising from inflammation [5]. Blocking those 
receptors may contribute to the effectiveness of opioids and lower the prevalence of 
chronic pain syndrome [1, 4]. An adverse side effect of ketamine is dose-dependent 
and could be avoided by using anxiolytics for premedication, selecting patients 
more carefully before the operation, using antihypertensive drugs together with 
ketamine infusion [3].
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U.S. Food and Drug Administration indications for the usage of ketamine are 
adjuvant to general anesthesia, induction agent for general anesthesia, sedation for 
short-time procedures [6]. This means that usage of ketamine for acute postopera-
tive pain treatment is not based on official indications, because there is a lack of 
researches on this topic.
In recent years, there has been considerable interest in ketamine efficiency in 
treating acute postoperative pain. Guidelines published in 2018 indicate that a regi-
men of low-dose ketamine can be described as following—ketamine bolus lower than 
0.35 mg/kg, infusion—lower than 1 mg/kg/h [5]. In 2015, Jouguelet-Lacoste with col-
leagues published a literature review that included five meta-analyses studying intra-
venous ketamine impact on postoperative pain inhibition. They revealed that ketamine 
lowers pain points and additional opioid consumption. Four out of five researches 
revealed that pain scores in the first 24 hours after operation lowered 87.5, 59, 54.5, and 
25% compared to placebo [7]. In 2018, Cochrane systematic review included 130 pieces 
of research to find if low-dose ketamine effectively alleviates acute postoperative pain. 
Consumption of opioids in the first 24 hours was 8 mg less and the first 48 hours 13 mg 
less when compared with placebo. Pain at rest lowered 5/100 mm of visual analog scale 
(VAS), during movement 6/100 mm VAS in the first 48 hours [8].
Unfortunately, there were no guidelines on what dosage, which patient group, 
and in what way ketamine should be used. In 2018, the American Society of 
Regional Anesthesia and Pain Medicine together with the American Academy of 
Pain Medicine and the American Society of Anesthesiologists published guidelines 
on intravenous usage of ketamine for managing acute pain. They indicated the most 
suitable group of patients for using ketamine, its dosage, indications, contraindi-
cations, and trials supporting this evidence. The authors of these guidelines also 
pointed out that more trials should be done to determine the accurate and effective 
doses of ketamine for effective acute pain management [6].
2. Methods
The design of this systematic review of the literature is followed by the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement 
guidelines. Data were identified from searches of MEDLINE (PubMed) database. 
The combination of keywords included terms “low” and “dose” and “ketamine” 
and “pain” and “postoperative” in PubMed Advanced Search Builder in all fields 
accordance with the PICO criteria: “Participants” were limited to 18 years and older, 
“interventions” covered were randomized controlled clinical trials on low-dose 
intravenous ketamine, “comparator”—comparing ketamine with placebo and/or 
a different dose of ketamine, and “outcomes” discovered after a thorough analysis 
of researches and classified according to the trial type and most common find-
ings. Records were screened by the title, abstract, and full text. Inclusion criteria 
were as follows: (1) full-text articles published in English; (2) not older than 2011; 
(3) double- or triple-blinded randomized prospective trials of different ketamine 
intravenous dosage and/or placebo; (4) American Society of Anesthesiologists 
(ASA) I–III class; (5) age over 18 years; (6) VAS or Numeric Pain Scale (NPS) used 
for evaluation of acute postoperative pain. However, review or meta-analysis or 
systematic review articles, commentaries, abstract-only publications, guidelines, 
case reports, not randomized trials, ketamine given intramuscularly/orally/subcu-
taneous, ketamine given in the emergency department were excluded. The detailed 
search flowchart is presented in Figure 1.
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3. Results
3.1 Study selection process
The research yielded 214 results, extracted from one database. All duplicates 
were removed, and 94 articles were checked manually for relevance by screening 
their titles and abstracts. About 51 results met the inclusion criteria, but only 
18 were included after a full-text review. Only full-text articles were selected 
because the information given in the abstract was not sufficient for the thorough 
analysis. The randomized trials, conducted in 2011–2020 and which compared 
different doses of ketamine and placebo given for patients during various surger-
ies to investigate the effect of the drug on the management of acute postoperative 
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3.2 Characteristics of included studies
Those 18 selected trials could be divided into several groups—those who inves-
tigate ketamine bolus dose (six trials), those who investigate different infusion 
dose peri- and postoperation (two trials), those who investigate both only during 
operation (six trials), and those who investigate bolus and infusion, which is 
continued during and after the operation (four trials). A summary of the results of 
18 analyzed studies is provided in Table 1.
3.3 Synthesis of results
All 18 trials (bolus/infusion/both) included in this systematic review were inves-
tigated and compared in three categories—pain, overall satisfaction, and adverse 
reactions (AR). The summarized results can be seen in Table 2.
Subramaniam and colleagues [9] conducted a trial wanting to find out ketamine 
impact on pain management after laminectomy. Pain scores remained high despite 
analgesic therapy with ketamine, epidural bupivacaine, PCA with hydromorphone, 
and other adjuvants. No adverse reactions in the ketamine group were observed. 
Meanwhile, Kim with fellow authors [19] conducted a similar trial, but in PCA, they 
used fentanyl. Their research revealed that 0.5 mg/kg ketamine bolus and 2 μg/kg/min 
ketamine infusion statistically significantly lower fentanyl doses in the first 48 hours 
after surgery without more frequent adverse reactions. In both trials, pain evaluation 
in points did not differ.
Chumbley with colleagues’ [24] trial revealed that 0.1 mg/kg IV ketamine bolus 
and 0.1 mg/kg/h infusion, started 10 min before thoracotomy, lowers consumption 
of opioids and pain scores at 48 h after surgery.
Yazigi with co-authors [18] injected IV 0.1 mg/kg ketamine bolus before the 
surgery and IV ketamine infusion of 0.05 mg/kg was continued for 72 hours after 
lobectomy during thoracotomy, same as bupivacaine that was injected through the 
intercostal catheter for 72 hours. Ketamine did not have any significant difference in 
pain scores, additional morphine consumption, sedation, and other adverse psycho-
mimetic effects.
Parikh with other scientists [10] aimed to find out the efficiency of pain man-
agement by using ketamine for patients after open renal surgery. They favored the 
use of ketamine, as its bolus and infusion started after anesthesia induction which 
reduced pain scores in the first 12 hours, reduced or delayed the use of additional 
postoperative morphine, and does not cause a more frequent adverse reaction.
Kaur and colleagues [22] discovered that ketamine bolus and infusion were 
given only during surgery lowered pain scores in the first 6 hours, reduced 
opioid consumption, and did not have an adverse effect on patients after 
cholecystectomy.
Nielsen with co-authors [14] investigated opioid-dependent patients’ pain 
management with ketamine bolus and infusion after back surgery. They did not 
find any difference in pain scores during 2–24 hours after surgery, but morphine 
consumption in the PCA in the first 24 hours was significantly lower in the research 
group. No statistical significance was observed on patients’ overall satisfaction and 
adverse reaction rate.
Haliloglu with colleagues [23] researched ketamine bolus and infusion during 
C-section. Their trial revealed that ketamine reduced postoperative PCA morphine 
consumption in the first 24 hours, but it did not reduce pain scores in the research 
group in all hours except for the first 15 min after surgery.
Ates with others [26] injected ketamine bolus and infusion during septorhino-































Author Year of publishing, 
country
Surgery type Number of 
patients
Type of anesthesia Inclusion criteria Pain and satisfaction evaluation
Subramaniam 
[9]
2011, USA Lumbar/thoracic 
laminectomy
30 General anesthesia Age 18 and older, ASA 1–3 
class
VAS (0–10 cm) at 0, 1, 2, 4, 8, 12, 18, 
24, 36, 48 h after surgery. Satisfaction 
on pain management at 48 h (1 p. bad, 
10 p. good)
Parikh [10] 2011, India Open renal surgery 60 General anesthesia Age 18–70, ASA 1–2 class VAS (0–10 cm) every 15 min at the first 
hour, and then at 4, 8, 12, 16, and 24 h 
after surgery
Bilgen [11] 2012, Turkey C-section 140 General anesthesia ASA 1–2 class, primiparas 
with an indication for 
C-section
NPS (0–10 p.) at 2, 6, 18, 24, 48 h after 
surgery
Mendola [12] 2012, Italy Muscle-sparing 
posterolateral 
thoracotomy
62 General and epidural 
anesthesia
ASA 1–3 class NPS (0–10 p.) at 1, 2, 4, 12, 18, 24 h and 
every 6 h following 3 days after surgery 
and 2 times a day until discharge
Song [13] 2013, Korea 1–2 level posterior 
lumbar fusion
50 General anesthesia ASA 1–2 class, non-
smoking women, age 
20–65, with a risk for 
postoperative nausea and 
vomiting
VAS (0–100 mm) at 30 min, 6, 12, 
24, 36, 48 h after surgery at rest and 
movement
Nielsen [14] 2017, Denmark 1–2 level middle 
lumbar fusion
147 General anesthesia Chronic back pain for 
>3 months, age 18–85, ASA 
1–3 class, BMI 18–40 kg/
m2, opioid usage for 
>6 months
VAS (0–100 mm) at 2, 6, 12, 18, 25 h 
after surgery at rest ant movement
Honarmand 
[15]
2011, Iran Appendectomy 90 General anesthesia ASA 1–2 class, age 18–60, 
no abscess or perforation
VAS (0–10 cm) at 0, 10, 20, 30 min, 
6–12–18–24 h after surgery.
Menkiti [16] 2012, Nigeria C-section 56 General anesthesia ASA 1–2 class, age 18–60, 
no abscess or perforation




2012, Croatia Laparoscopic 
cholecystectomy
80 General anesthesia ASA 1–2 class, age 18–70 VAS (0–10 cm) and numeric pain scale 
(0–4 p.) 0, 1, 2, 4, 6, 12, 24 h after the 
surgery. Overall satisfaction evaluated 

















Author Year of publishing, 
country
Surgery type Number of 
patients
Type of anesthesia Inclusion criteria Pain and satisfaction evaluation




60 General anesthesia and 
intercostal nerve block
ASA 2–3 class VAS (0–100 mm) 1, 6 12, 18, 24, 30, 36, 
42, 48, 54, 60, 66, 72 h after the surgery. 
Ramsav sedation scale (1–6 p.)




60 General anesthesia ASA 1–2 class VAS (0–100 mm) 1, 6, 24, 48 h after 
the surgery and movement. Overall 
satisfaction evaluated after 48 h (1–5 p.)
Han [20] 2013, Korea C-section 36 Spinal anesthesia ASA 1–2 class, between 37 
and 42 weeks of pregnancy
VAS (0–10) 2, 6, 24, 48 h after the 
surgery at a rest and while coughing 




2015, Iran C-section 160 Spinal anesthesia Singleton pregnancy Numeric pain scale (0–10 p.) 1, 2, 6, 
12 h after the surgery
Kaur [22] 2015, India Open cholecystectomy 80 General anesthesia ASA 1–2 class VAS (0–100 mm) 0, 2, 4, 6, 12, 24 h 
after the surgery. Overall satisfaction 
evaluated after 24 h (1–5 p.) Nausea and 
sedation evaluation (0–3 p.)
Haliloglu [23] 2016, Turkey C-section 52 General anesthesia ASA 1–2 class Numeric pain scale (0–10 p.) 15 min, 2, 
6, 12, 18, 24 h after the surgery
Chumbley [24] 2019, UK Thoracotomy 70 Not specified ≥18 years, able to read 
English
Numeric pain scale (0–10 p.) 24, 48 h 
after the surgery at a rest and while 
coughing
Boenigk [25] 2019, USA Two or more levels of 
lumbar spinal cord 
surgery
124 General anesthesia ASA 1–3 class Numeric pain scale (0–10 p.) 0, 30 min. 
1, 1. 5, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 
24 h after the surgery
Ates [26] 2020, Turkey Septorhinoplasty 48 General anesthesia ASA 1–2 class VAS (0–10 cm) 0, 1, 2, 4, 8, 12, 24 h 
after the surgery. Overall satisfaction is 
evaluated (1–5 p.)
Table 1. 







































Bolus and infusion during and after surgery





at 2 μg/kg/min during 
and after surgery for 
24 h
Same scheme, 






boluses every 5 min (max 
1.25 mg/h). Epidural 
block with bupivacaine. 
Nausea and vomiting—IV 
ondansetron 4 mg.




significant, the control 
group experienced 
nausea and AR-related 
to central nervous 
system (CNS) more 
often
—
Kim RG1—IV 1 μg/kg/min 
ketamine infusion 
started before incision 
and continued for 
48 h and 0.5 mg/kg 
ketamine bolus///
RG2—same scheme, 
but infusion at 2 μg/kg/
min and bolus 0.5 mg/
kg
Same scheme, 





max every 5 min. Nausea 
or vomiting—IV 10 mg 
metoclopramide/4 mg 
ondansetron.
RG2 used less fentanyl than 












Chumbley IV 0.1 mg/kg ketamine 
bolus 10 min before 
surgery and IV 0.1 μg/
kg/h ketamine infusion 
for 96 h
Same scheme, 







infusion of a local 
anesthetic
NPC 48 h after surgery 
lower in RG (p = 0.03). RG 




RG had vivid dreams 
and felt weaker than 
CG (p = 0.001 and 
p = 0.02).
Nausea, vomiting, 



























Yazigi Before the incision IV 
0.1 mg/kg ketamine 
bolus IV 0.05 mg/kg/h 
ketamine infusion for 
72 h
Same scheme, 
but instead of 
ketamine—IV 
NaCl 0.9%




catheter. Also IV 1 g 
paracetamol, 50 mg 
ketoprofen every 6 h. If 
VAS > 40 mm—morphine 
sulfate titrated 2 mg bolus 
max every 5 min, max 
dose 0.1 mg/kg/h
No statistical difference—
while coughing (p = 0.7), 




significant for sedation, 
dizziness, nausea, 
or vomiting. For 
two patients in RG 
had hallucinations, 
impaired vision, or 
nightmares.
—
Bolus and infusion only during surgery







infusion until the end 
of the surgery
Same scheme, 
but instead of 
ketamine—IV 
NaCl 0.9%
When VAS > 40 - >  
morphine 1 mg
In the first 12 h after the 
surgery VAS was lower in 
the RG. In RG 5 patients 
needed an additional 
analgesic, in CG all patients 
needed it so morphine 
consumption at RG was 
lower than in the KG.
Not 
examined





after the induction 
and IV 0.25 mg/kg 
ketamine infusion until 
the last stich
Same scheme, 
but instead of 
ketamine—IV 
NaCl 0.9%
For everyone in the first 
24 h—1 g paracetamol, 
orally every 6 h started 
from the 2nd h. PCA with 
2.5 mg morphine boluses 
max every 5 min. For 
nausea or vomiting IV 
4 mg ondansetron - > if 
not effective—droperidol
No statistical difference—
when moving (p = 0.63) 
and at the rest (p = 0.62) 







vomiting less frequent 








































Haliloglu At induction IV 0.5 mg/
kg ketamine bolus and 
infusion 0.25 mg/kg/h 
until the end of operation
Same scheme, 
but instead of 
ketamine—IV 
NaCl 0.9%
NPS >4 in the recovery 
room - > 0.05 mg/kg 
morphine. PCA 0.5 mg/kg 
morphine at 1 mg boluses 
max every 10 min. If PCA 
not efficient—IV 75 mg 
diclofenac.
15 min after the surgery NPS 
lower in the RG (p = 0.001) 
at 2, 6, 12, 18, 24 h—did 
not differ (p > 0.05). 
Consumption of morphine 
0–24 h was lower in the RG 
(p = 0.001)




dual vision did not 
occur to anyone. Most 
patients experienced 
nausea, vomiting, and 
itching, but no statistical 
difference (p > 0.05).
+
Kaur IV 0.2 mg/kg ketamine 
bolus and infusion 
0.1 mg/kg/h until the end 
of operation
Same scheme, 





bolus. Medium and strong 
nausea–IV 0.1 mg/kg 
ondansetron
During the first 6 h, VAS was 
lower in the RG (p < 0.05), 
but not different at 12 and 
24 h. RG patients needed 
less additional analgesic 
(p = 0.001). The usage of 









Nausea and vomiting 
were similar, but 
statistically not different.
+
Ates At induction IV 0.5 mg/





but instead of 
ketamine—IV 
NaCl 0.9%
For everyone at 12 and 24 h 
after the surgery—50 mg 
dexketoprofen. If 
VAS ≥ 4–1 mg/kg tramadol.
VAS was greater in the CG 
at 30 min. 1, 2, 4, 8, 12, 24 h 
(p < 0.05). CG needed more 
additional analgesics than RG 
(p = 0.022)
Higher 
in the RG 
(p = 0.003)
Nausea was more 
intense in the CG, but 
not statistically. RG 





Han IV 0.5 mg/kg ketamine 




but instead of 
ketamine—IV 
NaCl 0.9%
PCA with 25 μg/mL 
fentanyl—as needed, max 




At 2 h RG used less fentanyl 
(p = 0.033), but there was 










































but instead of 
ketamine—IV 
NaCl 0.9%
PCA for 48 h after the 
surgery - > morphine 
chloride 0.5 mg/mL - >  
1 mg bolus every 10 min. 
If needed—IV 75 mg 
diclofenac every 12 h. If 
NPS > 4, additional IV 
morphine 0.005 mg/kg.






0.7). In RG1—2 felt 
nausea, in RG2—3 
felt nausea, 1 vomited 
and 1 experienced 
hallucination, 
in RG3—4 had 
spontaneous, 
involuntary eye 
movement, 1 vomited 
and had an occurrence 
of dual sight, in the 
CG—1 felt nausea 





Song After induction IV 
0.3 mg/kg ketamine 





but instead of 
ketamine—IV 
NaCl 0.9%
PCA and 25 mg 
meperidine, when 
VAS > 40 mm or if the 
patient asks. When 
nausea >6 points (in the 
system of 10 points, 0—
no nausea, 10 strong and 
unbearable nausea) or if 
a patient asks—IV 4 mg 
ondansetron
No statistical difference—
when moving or at the rest. 
RG used less fentanyl 48 h 




RG felt nausea more 
common than CG at 
0–6 h (p = 0.016). 
RG experienced 
dizziness in the first 
























































0.4 mg/kg meperidine - >  
if it does not help in 
10 min - > 0.2 mg/kg. 
Do not exceed 2 mg/
kg in 4 h. Nausea 
>10 min. –0.1 mg/kg 
metroclopramide IV - >  
if needed, repeat after 
1 h.
VAS scores were lower at 
10, 20, 30 min in ketamine 
groups (p < 0.05) but did 
not differ between them. 
When comparing CG and 
RG groups at 6, 12, 18, 
24 h VAS were lower in 
RG (p < 0.05). At 12, 18, 
24 h VAS were lower in 





Sedation did not 
differ. AR did 





Menkiti IV 0.15 mg/kg 2 mL 
ketamine bolus after 
spinal anesthesia
Same scheme, 
but instead of 
ketamine—IV 
NaCl 0.9%
If VAS >3 IV 75 mg 
diclofenac. If it does 
not help - > 30 mg 
pentazocine 0, every 4 h 
and 75 mg diclofenac 
every 8 h if needed.
CG VAS was bigger at 60, 
90, 120 min. Statistically 
significant VAS > 3 p. 
differed at 90, 120, 
150 min. RG received less 

































Adam IV 100 mL NaCl 
0.9% 20 min. Before 
anesthesia and 0.15 mg/
kg 5 mL IV ketamine 
before incision///IV 
1 mg/kg diclofenac 
in 100 mL NaCl 
0.9% 20 min before 
anesthesia and 5 mL 
IV NaCl 0.9% before 
incision///IV 1 mg/kg 
diclofenac in 100 mL 
NaCl 0.9% 20 min 
before anesthesia and 
IV 0.15 mg/kg 5 mL 
ketamine before incision
IV 100 mL NaCl 
0.9% 20 min 
before anesthesia 
and 5 mL IV 
NaCl 0.9% before 
incision
If VAS > 4—diclofenac 
IV. If no effect—IV 1.25 g 
metamizole and IV 100 mg 
tramadol in 100 mL 0.9% 
NaCl per 20 min.
VAS max 1 h after surgery. 
Ketamine and diclofenac 
group pain scores lower than 
CG at 1, 2, 4, 6 h and lower 
than ketamine group at 1, 
2 h. During the first 6 h, pain 
scores were higher in CG 
rather than the ketamine and 
diclofenac group. During 
the first 4 h, ketamine and 
diclofenac are better than 
only ketamine. Diclofenac is 
better than CG or ketamine 












but instead of 
ketamine IV NaCl 
0.9%
If asked—100 mg rectal 
diclofenac suppository 
max every 6 h, max 4 
times in 24 h. If NPS 
≥5—intramuscular 50 mg 
petidine, max 2 times in 
24 h.
CG VAS bigger that RG at 
1, 2, 6, 12 h (p < 0.001). RG 
time until first analgesic 
longer than in the CG 
(p < 0.001). Total dose of 
petidine and diclofenac 
lower in the RG (p < 0.001).
Not 
examined
Vomiting is more 
common in CG 
(p = 0.020). 
Hallucinations are more 
common in the RG 
(p = 0.032).
+
Infusion during and after surgery




but instead of 
ketamine—IV 
NaCl 0.9%
If VAS > 3 p.— > PCA 
5 mL max every 60 min. 
If not—1) IV paracetamol 
45 mg/kg, 2) IV ketorolac 
1.5 mg/kg, 3) morphine
Not statistically significant 
between NPS. 0.1 day after 
















































Boenigk IV 0.12 mg/kg 
ketamine infusion for 
24 h and 0.2 mg/kg 
ketamine bolus during 
the first 30 min into 
Recovery Room
Same scheme, 
but instead of 
ketamine—IV 





max every 6 min, max 
2 mg/h for 24 h in the 
Recovery Room. If 
NPS > 4—IV 0.2–0.3 mg 
hydromorphone.
Not statistically significant 
between NPS. Opioid-
tolerant in RG consumed 
more hydromorphone 








Results of studies included in a systematic review.
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consumption of opioids, the adverse reaction occurred less frequently, and overall 
satisfaction on pain management was better.
Different from other trials, Han with colleagues [20] did not find any statisti-
cally significant difference in reducing pain scores, overall satisfaction, and adverse 
reactions.
Bilgen with other researches [11] evaluated three different IV ketamine bolus 
doses (0.25, 0.5, 0.1 mg/kg) in patients after C-section. No differences were 
observed.
Menkiti with colleagues [16] found that VAS > 3 points were significantly more 
often assessed in the control group at 90, 120, 150 min. Also, the first analgesic was 
appointed for patients for a short amount of time in the research group.
Rahmaniam with colleagues [21] researched IV ketamine bolus after C-section. 
In the ketamine group, pain scores were lower in the 1, 2, 6, and 12 hours after 
surgery. Time until first analgesic and amount of them was lower in the ketamine 
group. Unfortunately, nausea and hallucinations occurred more frequently in the 
ketamine group.
Song and fellow co-authors [23] researched IV ketamine bolus (which was 
also given in the PCA) impacts on pain management after spinal cord surgery. At 
48 hours, patients with PCA ketamine used less additional fentanyl than the control 
group. Also, research group participants experienced nausea at 0–6 hours and felt 
dizziness for 48 hours.
Honarmand and colleagues [15] discovered that 0.5 mg/kg IV ketamine bolus 
before appendectomy alleviates pain at 12, 18, and 24 hours better than the same 
dose given s/c or placebo.
Adam with other researchers [17] researched ketamine and diclofenac effects 
after laparoscopic cholecystectomy. It showed that ketamine without diclofenac has 
no significant difference.
Mendola and co-authors [12] were determined to find IV ketamine infusion, 
continued for 60 hours after surgery, impact on pain management. For 48 hours, 
the control group required more analgesics than the research group. Adverse reac-
tions were not more common in the ketamine group.
Boenigk and colleagues [25] researched 0.2 mg/kg IV ketamine bolus and 
0.12 mg/kg ketamine infusion on patients with and without opioid addiction. Those 
in the control group who have an addiction used more opioids for postoperative 
pain management than those who did not have an addiction.
4. Discussion
Multimodal analgesia is a key component for adequate and fulfilling postop-
erative pain management. Ketamine, together with adjuncts such as magnesium, 
lidocaine, dexamethasone, α2 agonists, incisional infiltration, acetaminophen, 
nonsteroidal anti-inflammatory drugs, or COX-2 selective given during surgery, is 
known to lessen the pain postoperatively by preventing neural sensitization that 
may lead to persistent pain as their primary purpose is to target the pain during 
various pathways in the central nervous system. Ketamine prescribed intravenously 
after the surgery may decrease overall opioid use, and it is a good analgesic for 
patients who develop tolerance to the analgesic properties of opioids [27].
The results of all these researches can be explained in several ways. Firstly, 
according to the type of surgery, Subramaniam [9] and Kim [19] investigated 
patients after spinal cord surgery, but Subramaniam [17] used IV ketamine 
0.15 mg/kg and Kim [19] used a much bigger dose—0.5 mg/kg IV ketamine bolus. 
Ketamine was infused at the same speed at 24 and 48 hours, respectively. These 
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reasons may have contributed to better outcomes of the Kim [19] trial, as patients 
used less postoperative analgesics when compared to the control group. Differently 
from these trials, Chumbley [24] and Yazigi [18] trial results cannot be explained 
like that, because IV ketamine bolus dose is the same, but Chumbley [24] used 
0.1 mg/kg/h infusion for 48 hours (more common adverse reactions—vivid dreams, 
poor well-being) and Yazigi [18] used 0.5 mg/kg/h for 78 hours, but the results were 
favorable to Chumbley [24] where patients needed less additional analgesics. As in 
Chumbley [24], trial patients felt adverse reactions more frequently the prospects of 
early rehabilitation of these people would have been weaker.
As for ketamine bolus and infusion only during surgery, we can state that 
carrying out open renal surgery [10] and cholecystectomy [22], IV ketamine bolus 
(0.15 mg/kg and 0.2 mg/kg), and infusion (2 μg/kg/min and 2 μg/kg/min) allevi-
ates pain better in the first 12 and 6 hours accordingly, reducing the postoperative 
amount of analgesics and not causing adverse reactions. Nielsen [14] trial (0.5 mg/
kg ketamine bolus and 0.25 mg/kg infusion) showed that patients who used 
opioids before surgery consume less morphine. Haliloglu [23] and Han’s [20] trials 
compared IV ketamine bolus 0.5 mg/kg and infusion 0.25 mg/kg—in the first one 
morphine consumption was lower in the research group for 24 hours, in the second 
one, no difference was observed. Best results were written in the Ates [26] trial 
(0.5 IV ketamine bolus and 0.25 mg/kg/h infusion)—pain scores, the demand of 
postoperative analgesics, and adverse reactions were lower in the ketamine group. 
Satisfaction of pain management was better in the ketamine group in only this trial.
Three trials compare the ketamine bolus effect on postoperative pain after 
C-section. In the first one [11], 0.25 mg/kg, 0.5 mg/kg, 1 mg/kg ketamine boluses 
did not have any impact on any factor. In the second one [16], 0.15 mg/kg ketamine 
bolus was determined to shorten the time of additional analgesia. In the third one 
[21], 0.25 mg/kg ketamine bolus revealed the best results—lower pain scores, longer 
time without analgesics and its dose, but nausea and hallucinations appeared more 
frequently. During spinal cord surgery [13], 0.3 mg/kg IV ketamine bolus triggered 
nausea and dizziness but lowered the number of additional analgesics. What is inter-
esting, 0.5 mg/kg IV ketamine bolus caused fewer adverse reactions after appendec-
tomy but also alleviated pain effectively in the first 24 hours after surgery [15]. A dose 
of 0.15 mg/kg IV ketamine bolus during laparoscopic cholecystectomy did not show 
any better results than a placebo. In only one trial, researchers investigated overall 
satisfaction which did not differ between the ketamine and placebo groups [17].
Comparing trials that investigated only ketamine infusion efficiency, we can 
summarize them into few fields—pain scores were not lower neither 0.1 mg/kg/h 
nor 0.12 mg/kg/h IV ketamine infusion. In the first research [12], the ketamine 
group required fewer postoperative analgesics. The same results were shown in the 
second trial, where patients before surgery used opioids [25]. Adverse reactions did 
not differ in any trial.
5. Conclusions
1. Pain intensity evaluated while using ketamine:
a. Bolus and infusion (during and after surgery)—IV combination of 0.5 mg/kg 
ketamine bolus and 1 μg/kg/min infusion successfully lowered the necessity of 
postoperative analgesics,
b. Bolus and infusion (during surgery)—IV combination of 0.5 mg/kg ketamine 
bolus and 0.25 mg/kg/h infusion successfully reduced postoperative pain and 
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IV 0.2–0.5 mg/kg bolus and 0.1–0.25 mg/kg/h infusion meaningfully  
diminished consumption of postoperative analgesics,
c. Infusion (during and after surgery)—IV 0.1 mg/kg/h ketamine bolus reduced 
consumption of postoperative analgesics,
d. Bolus—less analgesics were used when IV bolus dose were 0.25–0.3 mg/kg and 
IV 0.5 mg/kg bolus eased pain better for the first 24 h, 0.25 mg/kg for 12 h, 
0.15 mg/kg for 3 hours.
2. In 17 trials, overall well-being and satisfaction of pain management did not differ 
between ketamine and placebo and in one trial, 0.5 mg/kg ketamine bolus and 
0.25 mg/kg/h infusion were associated with better results.
3. Adverse reactions were more common in three pieces of research—the first  
being IV 0.1 mg/kg ketamine bolus and 0.1 mg/kg/infusion; second—IV 0.25 mg/
kg ketamine bolus; and third—IV 0.3 mg/kg ketamine bolus, thus meaning  
that the early rehabilitation of patients in the rest of the trials would have  
been good.
6. Practical recommendations
These recommendations are prepared in accordance with guidelines issued in 
2018 [6]:
1. Subanesthetic ketamine infusions should be considered for patients undergo-
ing painful surgery (upper and lower abdominal, thoracic, and orthopedic 
(limbs and spine)).
2. Ketamine should be considered for both opioid-tolerant and opioid-dependent 
patient groups.
3. Ketamine bolus should not exceed 0.35 mg/kg, infusion 1 mg/kg/g dose, but it 
should always be considered according to a patient’s factors.
4. Patients with cardiovascular disease, pregnant women, patients with active 
psychosis, hepatic dysfunction, elevated intracranial, and intraocular pressure 
should avoid using ketamine.
5. Intranasal ketamine should be considered using for children during short-time 
procedures and for whom intravenous ketamine is difficult to inject. Intranasal 
ketamine is effective for acute pain management and for amnesia and sedation 
during the procedure.
6. Evidence for the benefit of IV-PCA: Delivered ketamine as the only analgesic 
for acute pain is limited and there is moderate evidence for the benefit of the 
addition of ketamine to an opioid-based IV-PCA for acute and perioperative 
pain management.
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